TotalSeq™-D0352 anti-human FcεRIα antibody, FcεRIα, AER-37 (CRA-1),BioLegend,334651

Clone AER-37 (CRA-1) has been reported to bind the receptor even in the presence of IgE.4

Host

Mouse

Reactivity

Human

Application

PG - Quality tested

Platform ID

BAB579301326

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-D0352 anti-human FcεRIα antibody, FcεRIα, AER-37 (CRA-1)
Cat. No.334651
HostMouse
RRIDAB_2892406 (BioLegend Cat. No. 334651)
IsotypeMouse IgG2b, κ
ReactivityHuman
ApplicationPG - Quality tested
ClonalityMonoclonal
Clone NumberAER-37 (CRA-1)
Concentration0.5 mg/mL
TargetFcepsilonRIalpha
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-D oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

High affinity IgE receptor (FcεRI) plays a key role in IgE-mediated allergic immune response. FcεRI is a tetrameric receptor complex, which is composed of one α-subunit (FcεRIα), one β-subunit, and two γ-subunits. FcεRIα directly binds IgE with high affinity, while the β- and γ-chains are responsible for mediating intracellular signals. FcεRIα is a 50 kD transmembrane protein with Ig superfamily structure. It is primarily found on mast cells and basophils. Further studies have indicated that FcεRIα is also expressed on many inflammatory cells including cutaneuos Langerhans cells, dendritic cells, monocytes of patients with allergic disorders, platelets, bronchial epithelial cells, eosinophils produced in hypereosinophilic syndrome, and neutrophils from allergy-induced asthma patients.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.